Nexthera Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Nexthera Capital’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$1.77M	Buy	+5,668	New	+$1.89M	1.48%	18

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Nexthera Capital's REGN Position: Q2 2019 in Review

Nexthera Capital opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2019: 5,668 shares worth $1.77M. The stake represents 1.48% of the portfolio and ranks #18 among its holdings.

658 funds tracked by Wall St. Rank hold REGN as of Q2 2019.

Nexthera Capital held 5,668 shares of Regeneron Pharmaceuticals worth $1.77M as of Q2 2019.
Regeneron Pharmaceuticals was a new Nexthera Capital position in Q2 2019.
Regeneron Pharmaceuticals made up 1.48% of Nexthera Capital's portfolio in Q2 2019, its #18 holding.
658 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2019.

Based on Nexthera Capital's 13F filing for Q2 2019, filed 14 Aug 2019.